Significance of chronic marked hyperglycemia on FDG-PET: Is it really problematic for clinical oncologic imaging?

Annals of Nuclear Medicine

Volumn 23, Issue 7, 2009, Pages 657-669

  Hara, Tadashi ^a   Higashi, Tatsuya ^a,b   Nakamoto, Yuji ^a   Suga, Tsuyoshi ^a   Saga, Tsuneo ^c   Ishimori, Takayoshi ^a,d   Ishizu, Koichi ^a   Kawashima, Hidekazu ^a   Kawase, Shigeto ^a   Matsumoto, Keiichi ^e   Togashi, Kaori ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Shiga Medical Center Research Institute   (Japan)

^c NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^d KURASHIKI CENTRAL HOSPITAL   (Japan)

^e KYOTO COLLEGE OF MEDICAL SCIENCE   (Japan)

Author keywords

Diabetes; False negative; FDG PET; Hyperglycemia; Tumor

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18; GLUCOSE;

ADRENAL CANCER; ADULT; AGED; ARTICLE; BILE DUCT CANCER; BONE METASTASIS; BREAST CANCER; CANCER DIAGNOSIS; CANCER SIZE; CARCINOMATOUS PERITONITIS; CHEMOEMBOLIZATION; CHRONIC DISEASE; CHRONIC HYPERGLYCEMIA; COLORECTAL CANCER; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FALSE NEGATIVE RESULT; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HYPERGLYCEMIA; IMAGE ANALYSIS; LARYNX CANCER; LIVER CANCER; LIVER CELL CARCINOMA; LIVER METASTASIS; LUNG CANCER; LUNG METASTASIS; LYMPH NODE METASTASIS; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; PANCREAS CANCER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STOMACH CANCER; TREATMENT RESPONSE; UTERINE CERVIX CANCER;

ADULT; AGED; BLOOD GLUCOSE; CHRONIC DISEASE; DIABETES COMPLICATIONS; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES;

EID: 70349330490     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12149-009-0288-7     Document Type: Article

References (26)

1. JB Bomanji DC Costa PJ Ell 2001 Clinical role of positron emission tomography in oncology Lancet Oncol 3 157 164
2. RL Wahl CA Henry SP Ethier 1992 Serum glucose: effects on tumor and normal tissue accumulation of 2-[F-18]-fluoro-2-deoxy-d-glucose in rodents with mammary carcinoma Radiology 183 643 647
3. T Torizuka AC Clavo RL Wahl 1997 Effect of hyperglycemia on in vitro tumor uptake of tritiated FDG, thymidine, l-methionine and l-leucine J Nucl Med 38 382 386
4. S Zhao Y Kuge E Tsukamoto T Mochizuki T Kato K Hikosaka 2001 Effects of insulin and glucose loading on FDG uptake in experimental malignant tumours and inflammatory lesions Eur J Nucl Med 28 730 735
5. P Lindholm H Minn S Leskinen-Kallio J Bergman U Ruotsalainen H Joensuu 1993 Influence of the blood glucose concentration on FDG uptake in cancer-a PET study J Nucl Med 34 1 6
6. CG Diederichs L Staib G Glatting HG Beger SN Reske 1998 FDG-PET: elevated plasma glucose reduces both uptake and detection rate of pancreatic malignancies J Nucl Med 39 1030 1033
7. M Zimny R Bares J Fass G Adam U Cremerius B Dohmen 1997 Fluorine-18 fluorodeoxyglucose positron emission tomography in the differential diagnosis of pancreatic carcinoma: a report of 106 cases Eur J Nucl Med 24 678 682
8. 18F-FDG PET/CT 1.0 J Nucl Med 47 885 895
9. H Kitano Y Magata A Tanaka T Mukai Y Kuge K Nagatsu 2001 Performance assessment of O-18 water purifier Ann Nucl Med 15 75 78
10. M Gorenberg WA Hallett MJ O'Doherty 2002 Does diabetes affect [(18)F]FDG standardised uptake values in lung cancer? Eur J Nucl Med Mol Imaging 29 1324 1327
11. YC Chang TC Yen KK Ng LC See CH Lai TC Chang 2005 Does diabetes mellitus influence the efficacy of FDG-PET in the diagnosis of cervical cancer? Eur J Nucl Med Mol Imaging 32 647 652
12. E Hatano I Ikai T Higashi S Teramukai T Torizuka T Saga 2006 Preoperative positron emission tomography with fluorine-18-fluorodeoxyglucose is predictive of prognosis in patients with hepatocellular carcinoma after resection World J Surgery 30 1736 1741
13. T Higashi T Saga Y Nakamoto T Ishimori K Fujimoto R Doi 2003 Diagnosis of pancreatic cancer using fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET)-usefulness and limitation in "clinical reality" Ann Nucl Med 17 261 279
14. S Seo E Hatano T Higashi T Hara M Tada N Tamaki 2007 Fluorine-18 fluorodeoxyglucose positron emission tomography predicts tumor differentiation, P-glycoprotein expression, and outcome after resection in hepatocellular carcinoma Clin Cancer Res 13 427 433
15. GJ Cook S Houston R Rubens MN Maisey I Fogelman 1998 Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions J Clin Oncol 16 3375 3379
16. M Mamede T Higashi M Kitaichi K Ishizu T Ishimori Y Nakamoto 2005 [18F]FDG uptake and PCNA, Glut-1, and Hexokinase-II expressions in cancers and inflammatory lesions of the lung Neoplasia 7 369 379
17. S Seo E Hatano T Higashi A Nakajima Y Nakamoto M Tada 2008 Fluorine-18 fluorodeoxyglucose positron emission tomography predicts lymph node metastasis, P-glycoprotein expression, and recurrence after resection in mass-forming intrahepatic cholangiocarcinoma Surgery 143 769 777
18. A Namageyo-Funa P Nanavati 2008 The challenges of addressing primary prevention of diabetes: a response to recommendations from the chronic disease directors' project J Public Health Manag Pract 14 26 28 (Pubitemid 350307723)
19. R Schiel W Beltschikow T Steiner G Stein 2006 Diabetes, insulin, and risk of cancer Methods Find Exp Clin Pharmacol 28 169 175
20. T Nishikawa D Edelstein XL Du 2000 Normalizing mitochondrial superoxide production blocks three pathways of hyperglycemic damage Nature 404 787 790
21. LL Guyot FG Diaz MH O'Regan D Song JW Phillis 2000 The effect of topical insulin on the release of excitotoxic and other amino acids from the rat cerebral cortex during streptozotocin-induced hyperglycemic ischemia Brain Res 872 29 36
22. R Duelli MH Maurer R Staudt S Heiland L Duembgen W Kuschinsky 2000 Increased cerebral glucose utilization and decreased glucose transporter Glut-1 during chronic hyperglycemia in rat brain Brain Res 858 338 347
23. E Alpert A Gruzman H Totary N Kaiser R Reich S Sasson 2002 A natural protective mechanism against hyperglycemia in vascular endothelial and smooth-muscle cells: role of glucose and 12-hydroxyeicosatetraenoic acid Biochem J 362 413 422
24. S Nagamatsu H Sawa A Wakizaka T Hoshino 1993 Expression of facilitative glucose transporter isoforms in human brain tumors J Neurochem 61 2048 2053
25. C Peiró N Lafuente N Matesanz E Cercas JL Llergo S Vallejo 2001 High glucose induces cell death of cultured human aortic smooth muscle cells through the formation of hydrogen peroxide Br J Pharmacol 133 967 974
26. M Ishiki A Klip 2005 Minireview: recent developments in the regulation of glucose transporter-4 traffic: new signals, locations, and partners Endocrinology 146 5071 5078